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Pfficacy and Safety of
ircumferential Pulmonary Vein Isolation
sing a Novel Cryothermal Balloon Ablation System
lvaro V. Sarabanda, MD, PHD,*† T. Jared Bunch, MD,* Susan B. Johnson, BS,* Srijoy Mahapatra, MD,*
ark A. Milton, MD,* Luiz R. Leite, MD,* G. Keith Bruce, MD,* Douglas L. Packer, MD*
ochester, Minnesota; and Ribeirão Preto, Brazil
OBJECTIVES We sought to evaluate the efficacy and safety of a novel cryothermal balloon ablation system
in creating pulmonary vein (PV) isolation.
BACKGROUND Pulmonary vein isolation using standard radiofrequency ablation techniques is limited by
procedure-related complications, such as thrombus formation and PV stenosis. Cryothermal
ablation may reduce the risk of such complications.
METHODS Eight dogs underwent circumferential ablation of both superior PVs for either 4 or 8 min
using a cryothermal balloon catheter (CryoCath Technologies Inc., Kirkland, Canada). Both
fluoroscopy and intracardiac ultrasound (ICE)-guided balloon and Lasso catheter positioning
at the PV ostia assessed short-term PV integrity. In six additional dogs, long-term PV
integrity was assessed by computed tomography at 16 weeks after ablation.
RESULTS Successful electrical isolation was achieved acutely in 14 of 16 (87.5%) PVs and was confirmed
in one-week survival studies in 10 of 12 (83%) PVs. Successful isolation was higher in the
absence of any peri-balloon flow leak as seen by ICE (p  0.015), and with balloon
temperatures 80°C (p  0.015). Cryolesions were located at the veno-atrial junction and
were homogeneous, with intact endothelium and free of thrombus formation. Although
limited angiographic PV narrowing was noted in the early follow-up period, no significant PV
narrowing was seen long-term. Right phrenic nerve injury was seen in 50% of the animals
studied at one week.
CONCLUSIONS This novel cryothermal balloon ablation system is effective for isolating PVs, but injury to the
right phrenic nerve was noted in this early experience. Further studies are needed to assess the
long-term efficacy and safety of this technique. (J Am Coll Cardiol 2005;46:1902–12)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.046© 2005 by the American College of Cardiology Foundation
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aulmonary veins (PVs) play an important role in the
athogenesis of atrial fibrillation (AF), and their electrical
solation has been shown to be an effective treatment for this
rrhythmia (1–5). Although the success rate for radiofre-
uency AF ablation has improved as new anatomically and
lectrophysiologically based treatment strategies have been
ntroduced (1–5), a variety of procedure-related complications,
ncluding thromboembolic events, PV stenosis, and
sophageal-atrial fistula formation, remain a significant con-
ern and limit an even wider application of these techniques
1–6). Therefore, alternative energy sources and new abla-
ive strategies are being investigated (7–10).
Previous clinical and experimental investigations have
hown that cryoablation is a safe method of eliminating
ardiac arrhythmias (11,12). More recently, catheter-based
echniques have been developed and used for circumferen-
ial ablation around the PV ostia (7,8). Although initial
esults have been favorable, cryoablative procedures have
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ccepted July 15, 2005.een lengthy and efficacy variable (7,8). Safety also remains
o be established. These findings provide the incentive for
urther development of cryothermal energy delivery systems
o increase efficacy, reduce procedure times, and allow wider
pplication of this approach in the clinical arena.
We speculated that delivering cryoenergy at the veno-
trial junction via an occlusive balloon catheter would
acilitate the rapid isolation of PVs. The purposes of this
tudy therefore were to evaluate the efficacy and safety of a
ovel cryothermal balloon ablation system and establish the
ey contributors to ablative success.
ETHODS
eneral. The experimental protocol was approved by the
ayo Foundation Institutional Animal Care and Use Com-
ittee. Eight mongrel dogs weighing between 30 and 40 kg
ere used for this study. Animals were anesthetized with
ntravenous ketamine (10 mg/kg) and diazepam (0.5 mg/
g), intubated, and maintained on 1% to 3% isoflurane with
ositive-pressure ventilation. The body temperature was
aintained at 37°C. The surface electrocardiogram, tem-
erature, and blood pressure were continuously monitored
uring the procedure.
atheterization and PV mapping. Using tissue cut-downs
nd the Seldinger technique, hemostatic sheaths were
laced in the right and left external jugular veins and the
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November 15, 2005:1902–12 Cryoballoon Ablation of PVight femoral vein and artery. A 6-F decapolar catheter was
dvanced to the coronary sinus for anatomical guidance and
acing. A 7-F quadripolar catheter was positioned at the
ight atrium (RA)/superior vena cava (SVC) junction for
igh-output pacing of the phrenic nerve. Right heart hemo-
ynamic monitoring was assessed by a Swan-Ganz catheter.
ouble transseptal catheterization was accomplished under
oth fluoroscopic and intracardiac ultrasound (ICE) guidance
sing an 8-FMullins sheath and a Brockenbrough needle (13).
ntravenous heparin was given to attain an activated clotting
ime250 s. Before ablation, each targeted PV was mapped
ith a deflectable, circumferential decapolar catheter (Lasso
atheter, Biosense Webster, California), positioned at the
V ostium guided by biplane fluoroscopy.
elective PV angiography and ICE imaging. Selective
V angiography was performed through a multipurpose
ngiocatheter by hand injection of 10 ml of contrast
edium into the targeted vein. Pulmonary vein ostial
iameters were measured by angiography using the tech-
ique described by Lin et al. (14). The ICE imaging of the
eft atrium and PVs was performed via a 10-F, 5.5- to
0.0-MHz imaging frequency, deflectable phased-array ul-
rasound catheter, with pulsed and color Doppler flow
apabilities (AcuNav, Acuson Siemens Corp., Mountain
iew, California) advanced into the RA.
ryothermal balloon catheter. The cryothermal balloon
blation system (CryoCath Technologies Inc., Kirkland,
anada) consisted of a non-deflectable, over-the-wire 10-F
wo-lumen catheter with double inner-outer cooling bal-
oons (outer balloon maximum diameter, 23 mm; total
ength, 20 mm) (Fig. 1A). The refrigerant N2O was
elivered under pressure from the console into the inner
alloon chamber via a lumen within 2 mm of the catheter
ip, where it undergoes a liquid-to-gas phase change result-
ng in inner balloon cooling to temperatures 80°C.
uring cryotherapy, temperature was monitored via a thermo-
ouple located at the inner balloon.
blation. The balloon catheter was advanced over a guide-
ire through a 12-F, 65-cm-long sheath (Daig, St. Jude
edical Inc., Minnetonka, Minnesota) to the PV orifice, as
hown in Figure 1B. The balloon was then inflated and the
alloon-PV seal verified by both Doppler flow examination
nd repeated contrast injection through the central lumen of
Abbreviations and Acronyms
AF  atrial fibrillation
CT  computed tomography
ICE  intracardiac echocardiography
LA  left atrium
LSPV  left superior pulmonary vein
PV  pulmonary vein
RA  right atrium
RSPV  right superior pulmonary vein
SVC  superior vena cavahe catheter (Figs. 1B and 1C). The location of any seri-balloon flow leak was recorded and referenced to the
osition of the PV orifice. Cryoenergy was delivered to the
oldest achievable balloon temperature (80°C) to both
ight and left superior PVs, for either 4 or 8 min according
o pre-established randomization. Ablation was attempted
p to two times, or until complete elimination of all PV
otentials, as established by Lasso mapping repeated after
very cryoablation.
ne-week follow-up study. Two dogs were euthanized
mmediately after the ablation for histopathological exami-
ation. The remaining six animals were again instrumented
t 1 week, before euthanasia. Ventricular fibrillation was
nduced with high-rate burst pacing, and the animal was
xsanguinated.
ross pathology and histologic examination. The heart,
ungs, esophagus, trachea, and phrenic nerves were exam-
ned immediately for evidence of ablation effects and col-
ateral damage. The left atrium was carefully dissected, and
he PVs were then opened longitudinally to examine the
ndocardial surface with an incision along the 12 o’clock
oint of the vessel. After fixation with formalin, each
blated PV was embedded in paraffin and stained with
ematoxylin-eosin and Masson trichrome. The samples
ere examined histologically and the results correlated with
he key PV angiography, ICE, and Lasso catheter findings.
ong-term assessment of PV orifice dimension. In an
dditional six dogs, cryothermal ablation of both superior
nd inferior PVs was accomplished with the same size
alloon for 2 to 16 min. Long-term PV orifice size was
ssessed with contrast-enhanced spiral computed tomogra-
hy (CT) imaging, performed at baseline and repeated at 4
nd 16 weeks after ablation. The CT images were obtained
fter 125 ml of contrast injection, and the acquired set of
mages was reconstructed with a 0.6-mm interval (Vitrea,
nalyze software). Reconstructions of the ablated PVs were
valuated in two orthogonal planes, axial and coronal.
tatistical analysis. Continuous variables are reported as
ean  1 SD and were compared using the Mann-
hitney test or a t test for paired data, as appropriate. The
nalysis of variance test was used to compare baseline,
-week, and 16-week CT scan measurements. Categorical
ariables were compared using the Fisher exact test. Two
bservations from each dog were made in this study. An
ttempt was made to adjust for the potential correlation
etween these observations using generalized estimating
quation models. However, given the small number of
bservations and the results of the data, the models could
ot be estimated. A value of p  0.05 was considered
tatistically significant.
ESULTS
ryoablation of PVs. A total of 25 cryoapplications were
elivered to 16 PVs, including 14 applications to 8 right
uperior pulmonary veins (RSPV) and 11 cryoapplications
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Cryoballoon Ablation of PV November 15, 2005:1902–12o 8 left superior pulmonary veins (LSPV). The details of
he ablative procedure and its results are summarized in
able 1. The total duration of cryoablation per vein was
 3 min. In acute studies, successful electrical PV
solation, as indicated by elimination of PV potentials,
as achieved in 14 of the 16 (87.5%) attempted veins, as
hown in Figure 2.
eterminants of successful PV isolation at one-week
ollow-up. In animals that survived to one week, successful
lectrical isolation was seen in 10 of the 12 (83%) treated
Vs. Successful electrical isolation was obtained using
-min cryoapplications in 2 PVs and 8-min of cryoabla-
ion in 8 PVs (7 PVs [8 min], 1 PV [16 min]). The outcome
f ablation was not dependent on the treated PV (p 
igure 1. (A) Photograph of the cryothermal balloon catheter. (B) Fluoros
LSPV) orifice (arrows). (C) Intracardiac echocardiographic image of the
xample of an unsuccessful occlusion of the pulmonary vein orifice, with a p
rojection; RAO  right anterior oblique projection..455) or the number (p  0.455) or duration (p  1.0) of reezing, despite the occurrence of unsuccessful electrical
solation of the LSPV in two dogs. These two animals had
esidual PV potentials at the inferior portion of the LSPV
stium. The success rate for chronic PV isolation was
ignificantly higher in the absence of any peri-balloon flow
eak as evaluated by ICE (no leaks, 100% success; vs. any
eak, 0% success; p  0.015). Furthermore, the success rate
or chronic PV isolation was significantly higher with
chievement of balloon temperatures colder than 80.0°C
temperature 80°C: success in 10 of 10 veins, 100%; vs.
emperature 73°C: success 0 of 2 veins, 0%; p  0.015).
n these animals, the minimum balloon temperature
chieved during successful PV isolation was 81  1°C
range, 80°C to 83°C) and67 6°C (range,63°C to
image of the inflated balloon engaged at the left superior pulmonary vein
ed balloon positioned at the orifice of the LSPV (arrow), illustrating an
lloon flow leak as seen by color Doppler flow. LAO left anterior obliquecopic
inflat
eri-ba72°C) during unsuccessful PV ablation (p 0.0001) (Fig. 3).
Table 1. Ablative Approach and Results of Cryothermal Balloon Ablation of Pulmonary Veins
Dog No. Vein
No.
Cryoenergy
Application
Total
Duration
Application
(min)
Minimum
Ablation
Temperature
(°C)
Angiography
Leak
Pre-Ablation*
ICE Leak
Pre-Ablation
Immediate
Success†
One-Week
Success‡
Histopathologic
Evidence of
Complete PV
Lesion
Group I
1 RSPV 2 8 82 None No Yes NA NA
LSPV 2 8 54 Mod Yes No NA NA
2 RSPV 2 8 83 None No Yes NA NA
LSPV 1 4 81 Mild No Yes NA NA
Group II (one-week
survival dogs)
3 RSPV 1 4 82 None No Yes Yes Yes
LSPV 2 16 72 Mod Yes Yes No No
4 RSPV 2 8 81 None No Yes Yes Yes
LSPV 1 8 82 Mild No Yes Yes Yes
5 RSPV 2 16 82 None No Yes Yes Yes
LSPV 1 8 80 Mild No Yes Yes Yes
6 RSPV 1 4 81 None No Yes Yes Yes
LSPV 2 8 63 Mod Yes No No No
7 RSPV 2 8 81 None No Yes Yes Yes
LSPV 1 8 83 None No Yes Yes Yes
8 RSPV 2 8 81 Mild No Yes Yes Yes
LSPV 1 8 80 Mild No Yes Yes Yes
Mean  SD 1.5  0.5 8.2  3.4 78  8 14/16 10/12 10/12
*Angiographic peri-balloon flow leaks were classified as none: during contrast injection absence of any peri-balloon flow leak, with persistence of the contrast agent inside the PV for minutes; mild leak: presence of a temporary mild
peri-balloon flow leak related to the increased pressure inside the vein during contrast injection, with persistence of the contrast agent inside the PV for minutes; moderate leak: during contrast injection presence of a peri-balloon flow
leak, with quickly expelling of the contrast agent, but still allowing visualization of the venous structure; severe leak: during contrast injection presence of a peri-balloon flow leak, with quickly expelling of the contrast agent resulting in
poor visualization of the venous structure. †Persistence of PV entrance block 30 min after the last cryoapplication. ‡Persistence of PV entrance block at one-week after ablation.
ICE  intracardiac echocardiography; LSPV  left superior pulmonary vein; NA  not available; RSPV  right superior pulmonary vein.
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Cryoballoon Ablation of PV November 15, 2005:1902–12V angiography, ICE imaging, and Doppler flow studies. In
ll six surviving dogs, selective angiograms were repeated
efore euthanasia in 11 of the 12 treated PVs (Table 2).
nder baseline conditions, the mean ostial diameter of the
blated PVs was 10.5  1.0 mm, which decreased to 7.2 
.1 mm after the ablative procedure (p  0.001). In
ontrast, PV-LA mean pressure gradient and right heart
ressures were similar at baseline and after ablation.
On ICE imaging, a modest reduction of the PV orifice
imension was also noted after ablation (baseline 13.8 1.6
m vs. post-ablation 12.9  2.1 mm; p  0.05). The PV
ow velocities measured at one week post-ablation were not
ignificantly different from baseline in all ablated (0.47 
.09 vs. 0.52  0.06, p  0.586) and non-ablated veins
igure 2. Successful circumferential cryoablation of the left superior pul
ulmonary vein (PV) ostium. (B) Tracings of the surface electrocardiograph
o PV10-1) during distal coronary sinus pacing, and recorded before ablatio
igure 1.0.53  0.07 vs. 0.55  0.09, p  0.332). hong-term assessment of PV orifice dimension. To fur-
her assess the long-term impact of early PV narrowing on
utcome, we performed a second experiment in six addi-
ional dogs. Fifteen PVs were ablated (six LSPV, six RSPV
nd three LIPV), with a mean duration of cryoenergy
elivery of 6  5 min. The minimum balloon temperature
chieved was 71  7°C (range, 62°C to 80°C). On
T scan, PV orifice diameter was similar at baseline, at 4
eeks, and at 16 weeks after ablation at both the axial view
baseline, 13.4  2.2 mm; 4 weeks, 12.6  3.3 mm; and 16
eeks, 13.8  2.0; p  0.48) and coronal view (baseline,
5.0  3.2 mm; 4 weeks, 14.5  4.2 mm; and 16 weeks,
5.2  3.6 mm; p  0.47).
athological findings. In the six surviving dogs, gross and
ry vein. (A) Fluoroscopic image of the Lasso catheter positioned at the
s I and III and PV ostial electrograms as seen by the Lasso catheter (PV1-2
ft) and after ablation (right). LA  left atrium; other abbreviations as inmona
ic lead
n (leistologic examination showed a complete circumferential
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November 15, 2005:1902–12 Cryoballoon Ablation of PVnd transmural lesion at the veno-atrial junction in all
nstances in which successful PV electrical isolation was
btained (Fig. 4). Conversely, in the two unsuccessfully
solated LSPVs, a non-circumferential lesion gap at the
nferior aspect of the PV orifice was noted (Fig. 5).
nterestingly, the position of the lesion discontinuity
orresponded to both the location of the remaining PV
otentials as seen by the Lasso catheter and the peri-
alloon flow leak as seen by PV angiography and ICE
maging (Fig. 5).
At one week after ablation, cryolesions had well-
emarcated borders with inflammatory infiltrate, necrotic
yocardial cells, a mild degree of fibrosis, and a discrete
ubendothelial proliferation. In all lesions there was no
isruption of the endothelial surface and no evidence of
hrombus formation.
ollateral damage to adjacent structures. Failure to cap-
ure the right phrenic nerve despite maximum pacing output
igure 3. Impact of minimum balloon-tip temperature on outcome of
blation in 12 pulmonary veins. The minimum balloon-tip temperature
evels related to successful or unsuccessful pulmonary vein isolation (PVI)
re shown. Temperature values in some pulmonary veins overlap.
able 2. Distribution of Pulmonary Vein Ostial Diameters and D
Dog No. PV
Angiography Mean PV
Ostial Diameter (mm)
Baseline Post-Ablation
roup II (one-week
chronic studies)
3 Ablated* 10.9 6.1
4 Ablated* 9.8 7.4
5 Ablated* 11.2 8.8
6 Ablated* 8.7 6.0
7 Ablated* 11 8.1
8 Ablated* 11.2 6.6
Mean  SD 10.5  1.0 7.2  1.1‡
3 Non-ablated† NA NA
4 Non-ablated† NA NA
5 Non-ablated† NA NA
6 Non-ablated† NA NA
7 Non-ablated† NA NA
8 Non-ablated† NA NA
Mean  SD NA NARight and left superior pulmonary veins. †Right and left inferior pulmonary veins. ‡p  0
ICE  intracardiac echocardiography; NA  not available; PV  pulmonary vein.20 mA) was seen in four of the eight dogs in the immediate
ost-ablation evaluation, and remained unsuccessful in all three
nimals surviving to one week. In these four animals, evidence
f right phrenic nerve injury was observed on gross inspection,
s shown in Figure 6A. There was no correlation between
hrenic nerve injury and either the number or total duration of
reezing. There was no evidence of injury to the esophagus or
rachea on gross examination. A minor lung injury adjacent to
he RSPV ostium was noted in one of the eight studied dogs.
ISCUSSION
his study provides substantial information regarding the
fficacy and safety of novel cryothermal balloon technology
n creating PV isolation. First, cryoablation was highly
ffective, although this is a short-term study and our results
ay not represent the long-term response of cryolesions.
econd, optimal balloon-tissue contact was required for
uccessful PV isolation. Third, electrical isolation of PVs
orrelated closely with circumferential and transmural le-
ions at the veno-atrial junction. Fourth, cryolesions were
omogeneous, with intact endothelium, and were free of
hrombus formation. Fifth, although limited angiographic
V narrowing was noted in the early follow-up period, no
ignificant PV narrowing was seen on long-term follow-up.
inally, right phrenic nerve injury was common in the early
xperience with this technique.
Cryoablation through various systems has been used
uccessfully for PV isolation (7,8). For example, one study
sed a catheter-based technique for cryoablation with cir-
umferential point-by-point ablation around the PV ostia
uided by a Lasso catheter (7). The long-term efficacy with
his approach was 71% without evidence of PV stenosis.
owever, the technique required high interventional exper-
ise and was associated with long procedure times (7 to 8 h).
n comparison with current radiofrequency ablation ap-
ler Flow Velocities
ography
duction
ameter
ICE Mean PV Ostial
Diameter (mm)
ICE PV Doppler Flow
Velocity (m/s)
Baseline Post-Ablation Baseline Post-Ablation
44 13.2 11.6 0.54 0.50
24 12.4 10.6 0.35 0.61
21 14.5 15.2 0.45 0.45
31 13.7 12.6 0.38 0.48
26 16.7 15.8 0.56 0.56
41 12.4 11.5 0.57 0.55
 9 13.8  1.6 12.9  2.1‡ 0.47  0.09 0.52  0.06
NA 11.9 11.8 0.65 0.50
NA 11.4 13.6 0.47 0.74
NA 13.5 12.0 0.49 0.55
NA 11.7 11.0 0.50 0.48
NA 12.9 12.5 0.52 0.51
NA 12.8 15.2 0.57 0.53
NA 12.4  0.8 12.7  1.5 0.53  0.07 0.55  0.09opp
Angi
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Cryoballoon Ablation of PV November 15, 2005:1902–12roaches for paroxysmal atrial fibrillation (1–4), the success
ate was lower and the procedure times were longer. These
imitations prompted investigation of novel technologies
uch as balloon-based systems that would be less dependent
n operative expertise and decrease procedure times (9,15).
Our findings extend the results of previous experimental
tudies (9,15) reporting the use of cryoballoon technology
or PV isolation. In prior studies, cryoballoon ablation was
uccessful in reducing P-wave activity in the ablation zone,
ecreasing inducibility of atrial fibrillation, and reducing
ocal PV electrogram amplitudes (9,15). Although these
reliminary studies suggested a potential benefit from
ryoballoon-based systems, our observations clarify the clin-
igure 4. Complete circumferential and transmural lesion at the veno-atria
ein as seen in Figure 2. (A) Fluoroscopic image of the inflated balloon e
howing a well-demarcated lesion at the veno-atrial junction that extended
ar  1 mm), photomicrograph of a transverse section at the veno-atrial j
ulmonary vein; LMPV  middle branch of the left superior pulmonarycal efficacy using a more rigorous elimination of all PV (ctivity as an end point. These data also document the
rerequisites for successful PV isolation and potential lim-
tations of this approach. Furthermore, they show the value
f balloon occlusion as measured by intracardiac echocardi-
graphy on procedural success.
In animals surviving to one week, successful electrical
solation was possible in 83% of the treated PVs. In animals
ith electrical PV isolation, a complete circumferential cryole-
ion was observed at the veno-atrial junction. However, the
asso catheter specifically identified the location of the histo-
ogic lesion gap. The rate of PV electrical isolation observed in
his study is similar to or better than that achieved with
natomic-based approaches using radiofrequency energy
tion of the left superior pulmonary vein (LSPV). Same ablated pulmonary
d at the LSPV orifice (arrows). (B) Photograph of the left atrium open
wide area outside the LSPV ostium. (C) (Masson trichrome stain; 2.5;
n; a circumferential and transmural lesion is shown. LIPV  left inferior
other abbreviations as in Figure 1.l junc
ngage
to a
unctio2,16).
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November 15, 2005:1902–12 Cryoballoon Ablation of PVThe long-term impact of lesion gaps is uncertain. Ouyang
t al. (17) reported outcomes in 41 patients with symptom-
tic paroxysmal atrial fibrillation undergoing continuous
ircular lesions around the PVs. After six months, recurrent
trial fibrillation developed in 24% with gaps found in the
ircumferential lines in all patients studied. Furthermore, in
ight of nine (89%) patients, closure of these gaps resulted
n freedom from recurrent atrial fibrillation. The impact of
ncomplete isolation of PVs with cryotherapy on successful
igure 5. Example of unsuccessful cryoablation of the left superior pulmon
SPV orifice shows an unsuccessful occlusion of the pulmonary vein (PV)
asso catheter at the LSPV orifice during repeated mapping at one week
V10-1) as shown in panel B. Note that the remaining PV potentials (ar
ndocardial surface of the left atrium showing a non-circumferential lesion
ote that the position of the lesion gap corresponded to both the locatio
richrome stain; 2.5), photomicrograph of a transverse section at the venlimination of arrhythmia remains to be elucidated in tong-term models, because others have suggested that com-
lete elimination of all gaps may not be necessary for
uccessful elimination of AF (2,16).
In this study, 17% of the PVs were not successfully isolated,
hich allows analysis of cryoballoon therapy characteristics
ssociated with efficacy. First, our data underscore the need of
ptimal balloon-tissue contact for successful electrical isolation
f PVs. Complete balloon-tissue contact allows circumferential
elivery of cryotherapy, which, as seen in this study, impacts
in (LSPV). (A) Venography through the inflated balloon positioned at the
ce, with a peri-balloon flow leak at its inferior aspect. (B) Position of the
blation. (C) The PV potentials recorded by the Lasso catheter (PV1-2 to
predominated at the inferior aspect of the vein. (D) Photograph of the
e veno-atrial junction, with the arrow pointing to the lesion discontinuity.
he remaining PV potentials and the peri-balloon flow leak. (E) (Masson
ial junction. Abbreviations as in Figure 5.ary ve
orifi
after a
rows)
at th
n of the minimum temperature achieved. Optimal contact is de-
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Cryoballoon Ablation of PV November 15, 2005:1902–12endent on the size of the balloon and its relationship to PV
hape and size. Specifically, in two animals in which the
alloon size was much larger than the LSPV orifice, incom-
lete occlusion of the vein orifice resulted in an ineffective
blation. In this study, ICE was successful in each case in the
dentification of peri-balloon leak that was directly correlated
ith PV isolation failure. These data suggest that ICE use to
dentify peri-balloon leak and the availability of variable-sized
alloons may overcome inherent anatomic barriers and en-
ance procedural success.
These data show that cryoapplications with balloon temper-
tures colder than 80°C were important to maximize suc-
essful PV isolation. Low temperatures were obtained with
niform and complete contact between the balloon and the PV
all. This would be expected to limit passive convective
eating of the balloon and downstream atrial tissue by leaking
lood flow. These data also expand other previous in vivo
tudies that reported therapy success when temperatures rang-
ng from 30°C to 80°C were achieved at the PV orifice
8,9,15). The end points of this study requiring complete
lectrical isolation of PVs support a specific balloon tempera-
ure of 80°C.
In this study, cryolesions were extensive and located outside
he PV orifice, which underscores another potential advantage
f cryothermal balloon technology in creating PV isolation.
ith cryoablation, once complete PV occlusion is achieved,
igure 6. Phrenic nerve injury as seen on gross inspection. (A) Right phre
he right superior pulmonary vein (RSPV) ostium is visible, extending to a
mage illustrating the relative proximity of the right phrenic nerve course to
all of the superior vena cava (SVC) depict the site where successful phre
s marked with arrowheads. CS coronary sinus; IVC inferior vena cava
s in Figure 1.he orientation of the balloon at the PV orifice may be less celevant for successful PV isolation than for other balloon
blation technologies, such as ultrasound (10) and laser-based
18) balloon ablation systems, with a focused energy source.
ith the present cryoballoon system, provided temperature is
niform throughout the balloon, a circumferential lesion
hould be feasible at the PV orifice once complete balloon-
issue contact is achieved around the vein.
We sought to rigorously assess procedural-related com-
lications resulting from this cryoballoon ablation system.
he cryolesions had well-demarcated borders, with replace-
ent of the muscular sleeve with inflammatory infiltrate and
brotic tissue and without endothelial surface thrombus
ormation. These findings were consistent with previous
bservations using cryoenergy for ablating cardiac tissue
9,11,15).
In this study, modest angiographic PV ostial narrowing
as seen in the early follow-up period, although these
hanges were not associated with untoward physiological
equelae. However, an additional chronic safety study con-
ucted in our laboratory showed no long-term narrowing on
epeated CT scanning over the course of four months after
blation. This apparent discrepancy may be related to
ransient edema or spasm occurring early after cryoablation,
ith resolution on long-term follow-up. Our observations
onfirm the results obtained in a previous experimental
tudy using another balloon technology and repeated
erve course is visible after deflecting the right lung rightward. A lesion at
nt structures and encompassing the right phrenic nerve. (B) Fluoroscopic
inflated balloon engaged at the RSPV antrum. Arrows at the anterolateral
rve capture was obtained. The plausible course of the right phrenic nerve
 right atrium; RIPV right inferior pulmonary vein; other abbreviationsnic n
djace
the
nic neryoenergy applications at the PV-LA junction (15), which
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November 15, 2005:1902–12 Cryoballoon Ablation of PVeported no PV stenosis or narrowing over the course of
hree months after ablation.
Phrenic nerve injury has been reported in patients under-
oing radiofrequency-based (5) and cryoenergy-based cath-
ter isolation of PVs (7) as well as with newer ablation
alloon technologies (10). The incidence of phrenic nerve
njury in our study was higher than expected. A potential
xplanation for this may be that the ablation procedure was
erformed with an undersized balloon positioned well into
he RSPV antrum, and as a consequence cryoenergy had to
e delivered twice, targeting each RSPV branch individu-
lly, to successfully isolate the RSPV antrum. Because the
hrenic nerve courses closely to the RSPV orifice (Figs. 6A
nd 6B), it is conceivable that positioning the cryoballoon
nside the RSPV antrum and delivering repeated cryoenergy
ight have increased the risk of phrenic nerve injury. A
arger balloon catheter will be required to avoid this com-
lication.
Second, balloon techniques may create a local environ-
ent conducive to enhanced “cold” transfer to deeper
issues. In vitro studies have shown that the distance of
reezing from the energy source is dependent on the speed
f ice growth, which in turn is related to initial temperature
chieved, and inversely related to the tissue thickness and
emperature gradient (19). In our study, the balloon oc-
luded flow completely in all but one RSPV. This charac-
eristic of the device in the RSPV allowed rapid freezing of
he tissue to levels at or below 80°C. Because the balloon
as within the RSPV antrum in four cases, the distance
rom the balloon to the phrenic nerve and the amount of
issue between the nerve and balloon were decreased.
xpected phrenic nerve recovery could not be assessed over
he one week of follow-up in this study.
Finally, although a minor lung injury adjacent to the
SPV ostium was observed in one of the eight dogs studied,
one of the surviving animals had any symptoms attribut-
ble to lung injury such as hemoptysis.
tudy limitations. The findings of this early experience
ith this new cryoballoon technology should be interpreted
n light of several limitations. First, cryothermal ablation of
Vs was evaluated using a single shape and size of balloon
atheter without a deflectable tip for guidance. Because the
natomy of the dog does not generally allow positioning of
he balloon catheter within inferior PVs without deflecting
ts tip or using specialized deflectable or curved sheaths,
blation of inferior PVs was not addressed in our study.
uture balloon catheter models would require different
hapes and sizes and a deflectable tip to overcome inherent
natomic barriers and enhance procedural success. This
tudy also fails to precisely clarify the amount of cryoenergy
hat should be delivered to successfully isolate PVs. It
emains unknown whether cryoapplications lasting 4 min
re equally as effective as cryoapplications 4 min duration
hile limiting phrenic nerve injury risk. Another limitation
f the present study is that the pathological effects of
ryotherapy were investigated only at one week after abla-ion period, whereas prior studies have shown that cryole-
ions may take up to 12 weeks to fully maturate. Thus, it
hould be stressed that this is a short-term study and that
ur results may incompletely represent the long-term re-
ponse of cryolesions. Further studies are needed to assess
he long-term efficacy and safety of this novel technique.
inally, data from an in vivo canine model may vary from
uman tissue characteristics and responses in patients with
trial fibrillation.
linical implications. The efficacy of the novel cryobal-
oon ablation system for isolating PVs seen in the present
tudy supports the utility of this technique in ablating PVs
n the clinical electrophysiological laboratory. A cryoballoon
pproach to PV isolation is attractive because isolation of
Vs can be quickly performed through a simple anatomical
pproach based on balloon positioning at the PV orifice.
owever, because of the variability of the PV anatomy, a
amily of balloon catheters with variable shapes and sizes
ill be required to fully implement this technique. The
mpact of this new technique on collateral injury remains to
e elucidated completely.
eprint requests and correspondence: Dr. Douglas L. Packer,
ayo Clinic, Saint Mary’s Hospital, 1216 2nd Street SW AL
-416, Rochester, Minnesota 55902. E-mail: packer.douglas@
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